Analytical Data
-
基因名
CCNB1IP1
- Application
-
别名
C14orf18; CCNB1IP1; Chromosome 14 open reading frame 18; CIP1_HUMAN; Cyclin B1 interacting Protein 1; cyclin B1 interacting Protein 1; E3 ubiquitin Protein ligase; Cyclin-B1-interacting Protein 1; E3 ubiquitin-Protein ligase CCNB1IP1; Enhancer of invasion 10; Gm288; HEI10; Human enhancer of invasion 10; mei4
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NPC3
-
表达区间
1-277aa
-
氨基酸序列
MSLCEDMLLCNYRKCRIKLSGYAWVTACSHIFCDQHGSGEFSRSPAICPACNSTLSGKLDIVRTELSPSEEYKAMVLAGLRPEIVLDISSRALAFWTYQVHQERLYQEYNFSKAEGHLKQMEKIYTQQIQSKDVELTSMKGEVTSMKKVLEEYKKKFSDISEKLMERNRQYQKLQGLYDSLRLRNITIANHEGTLEPSMIAQSGVLGFPLGNNSKFPLDNTPVRNRGDGDGDFQFRPFFAGSPTAPEPSNSFFSFVSPSRELEQQQVSSRAFKVKRI
-
分子量
57.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCNB1IP1, also known as cyclin B1-interacting protein 1, is a protein that has garnered significant attention in cancer research due to its role in cell cycle regulation and potential implications in tumorigenesis. This protein is known to interact with cyclin B1, a key regulator of the cell cycle that promotes the transition from G2 phase to mitosis. Dysregulation of cell cycle proteins, including CCNB1IP1, can lead to uncontrolled cell proliferation, a hallmark of cancer development. Studies have indicated that alterations in CCNB1IP1 expression may correlate with tumor progression and the aggressiveness of certain cancer types, suggesting that it could serve as a potential biomarker for cancer diagnosis and prognosis. Furthermore, understanding the molecular mechanisms underlying CCNB1IP1's role in the cell cycle can provide insights into novel therapeutic strategies targeting cell cycle checkpoints. Recent research initiatives have aimed to elucidate the functional pathways associated with CCNB1IP1, including its interactions with other cell cycle regulators and signaling molecules. Investigating the reconstitution of CCNB1IP1 in various experimental models may shed light on its biological significance and therapeutic potential, paving the way for innovative treatments aimed at manipulating cell cycle dynamics in cancer therapy. Overall, the study of CCNB1IP1 and its roles in cellular processes highlights its importance as a target in oncology, warranting further investigation into its functionality and regulatory mechanisms, especially in the context of cancer.
